These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Out patient prophylaxis of arrhythmias due to coronary insufficiency (author's transl)]. Laurencet FL Schweiz Rundsch Med Prax; 1976 Jan; 65(3):67-9. PubMed ID: 3777 [No Abstract] [Full Text] [Related]
3. Rational use of antiarrhythmic drugs alone and in combination. Bigger JT; Giardina EG Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454 [No Abstract] [Full Text] [Related]
4. [Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice]. Iur'ev EG; Iur'eva TI Farmakol Toksikol; 1973; 36(1):29-32. PubMed ID: 4685151 [No Abstract] [Full Text] [Related]
5. [Clinical pharmacology of anti-arrhythmic drugs and medical treatment of arrhythmias]. Botti G; Visioli O; Bianchi C Atti Soc Ital Cardiol; 1966; 2():226-64. PubMed ID: 5991630 [No Abstract] [Full Text] [Related]
6. Reappraisal of digitalis. X. Treatment of digitalis toxicity. Lyon AF; DeGraff AC Am Heart J; 1967 Jun; 73(6):835-7. PubMed ID: 4961018 [No Abstract] [Full Text] [Related]
7. [Pharmacological treatment of arrhythmia]. Kuch J Pol Tyg Lek; 1983 Jan; 38(3):103-8. PubMed ID: 6135199 [No Abstract] [Full Text] [Related]
8. [Arrhythmia caused by digitalis and its treatment]. Stazi C; Marasà G Ann Med Nav (Roma); 1972; 77(1):51-80. PubMed ID: 4401945 [No Abstract] [Full Text] [Related]
9. Mechanisms contributing to dysrhythmias induced by ischemia and their therapeutic implications. Corr PB; Sobel BE Adv Cardiol; 1978; (22):110-29. PubMed ID: 22992 [No Abstract] [Full Text] [Related]
10. Use of anti-arrhythmic agents other than digitalis. Dreifus LS Calif Med; 1970 Feb; 112(2):80-2. PubMed ID: 4394266 [No Abstract] [Full Text] [Related]
11. Use of anti-arrhythmic agents other than digitalis. Dreifus LS J Iowa Med Soc; 1970 Mar; 60(3):192-3 passim. PubMed ID: 4391880 [No Abstract] [Full Text] [Related]
12. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats]. Ammar EM; Kudrin AN Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670 [No Abstract] [Full Text] [Related]
14. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide]. Igarashi T; Hashimoto N Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706 [No Abstract] [Full Text] [Related]
15. [Basic comments on the treatment of arrhythmias]. von Knorre GH Z Arztl Fortbild (Jena); 1977 Apr; 71(8):382-5. PubMed ID: 878507 [No Abstract] [Full Text] [Related]
17. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias]. Cosnier D; Grimal J; Duchene-Marullaz P Therapie; 1971; 26(1):97-107. PubMed ID: 5554772 [No Abstract] [Full Text] [Related]
18. [Possibilities of drug therapy of arrhythmias in myocardial infarct]. Kozená J; Kolár J Cas Lek Cesk; 1971 May; 110(19):437-41. PubMed ID: 5574742 [No Abstract] [Full Text] [Related]
19. Clinical cardiology. Use of anti-arrhythmic agents other than digitalis. Dreifus LS J Kans Med Soc; 1970 Jul; 71(7):276-8. PubMed ID: 4393787 [No Abstract] [Full Text] [Related]
20. Pharmacology of the myocardium: antiarrhythmic therapy. Julian DG Proc R Soc Med; 1976 Mar; 69(3):211-3. PubMed ID: 1265016 [No Abstract] [Full Text] [Related] [Next] [New Search]